发明名称 miR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR-215, miR-216, miR-331, mmu-miR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
摘要 The present invention concerns methods and compositions for identifying genes or genetic pathways modulated by miR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR-215, miR-216, miR-331, mmu-miR-292-3p, and using nucleic acid comprising all or part of the miR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR-215, miR-216, miR-331, mmu-miR-292-3p sequences to modulate a gene or gene pathway, using this profile in assessing the condition of a patient and/or treating the patient with an appropriate miRNA.
申请公布号 US2009131356(A1) 申请公布日期 2009.05.21
申请号 US20080167492 申请日期 2008.07.03
申请人 ASURAGEN, INC. 发明人 BADER ANDREAS G.;BYROM MIKE W.;PATRAWALA LUBNA;JOHNSON CHARLES D.;BROWN DAVID
分类号 A61K31/7105;C12N15/11;C12N15/113;C12Q1/68 主分类号 A61K31/7105
代理机构 代理人
主权项
地址